Press Releases - Pfizer
WEBPfizer’s BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically Meaningful Response in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer. 09.11.2024. Research and Pipeline.
Newsroom - Pfizer
WEB6 days ago · Updates and Statements. Pfizer Receives Positive CHMP Opinion for its Treatment for Adults and Adolescents with Hemophilia A and B. Pfizer Statement on Publication of ELIQUIS® Maximum Fair Price. View All Updates and Statements.
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
WEBDec 11, 2020 · COMIRNATY is the first COVID-19 vaccine to be granted FDA approval. Approval is based on a comprehensive submission package including six-month efficacy and safety data after second dose. More than 1.2 billion Pfizer-BioNTech doses have been delivered to more than 120 countries or territories around the world since December 2020.
Pfizer rolls out another cost-cutting program, sets $1.5 billion …
WEBMay 22, 2024 · U.S. drugmaker Pfizer on Wednesday launched a new multi-year program to reduce its expenses by about $1.5 billion by the end of 2027, adding on to a $4 billion cost cutting plan it announced last...
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAugust 22, 2024. Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent...
Pfizer Inc. (PFE) Latest Stock News & Headlines - Yahoo Finance
WEBGet the latest Pfizer Inc. (PFE) stock news and headlines to help you in your trading and investing decisions.
FDA Approves First COVID-19 Vaccine
WEBFDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease...
Pfizer Stock Jumps On 'Massive' Upside Thanks To Paxlovid Surprise
WEBMay 1, 2024 · Pfizer (PFE) stock surged Wednesday after the pharma giant walloped analysts' first-quarter earnings forecast and delivered better-than-expected sales on the back of Covid treatment Paxlovid....
CDC identifies possible safety issue with Pfizer’s updated ... - CNN
WEBJan 13, 2023 · The US Centers for Disease Control and Prevention said Friday that there is a possible safety issue with the bivalent Covid-19 vaccine made by Pfizer and BioNTech but that it is unlikely to ...
FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better …
WEBSep 11, 2023 · As part of today’s actions, the bivalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States.
- Some results have been removed